ArticleEuropean journal of clinical pharmacology2026

CYP2C19 genotyping and mavacamten: predicting outcomes in normal, intermediate and rapid metabolisers in obstructive hypertrophic cardiomyopathy.

Yande Kasolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.